Penumbra (PEN) Other Operating Expenses (2018 - 2024)
Penumbra (PEN) reported Other Operating Expenses of $76.9 million for Q2 2024, up 322.43% on a QoQ basis from $18.2 million in Q3 2023.
Penumbra (PEN) has 3 years of Other Operating Expenses data on file, last reported at $76.9 million in Q2 2024.
- Quarterly Other Operating Expenses changed N/A year-over-year to $76.9 million in Q2 2024, while the trailing twelve-month figure through Mar 2025 was $76.9 million (up 322.43% YoY) and the FY2024 annual result came in at $76.9 million, up 322.43% from the prior year.
- Other Operating Expenses rose to $76.9 million in Q2 2024 per PEN's latest filing, from $18.2 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $76.9 million in Q2 2024 and bottomed at $18.2 million in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Penumbra | 12.52 Bn | 11.91 Bn | 253.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 76.95 Mn |
| Sep 30, 2023 | 18.22 Mn |
| Sep 30, 2018 | 30.84 Mn |